Title
Drug Regulation And Innovation: Empirical Evidence And Policy Options (Evaluative Studies, 28)
Processing time: 1-3 days
US Orders Ships in: 3-5 days
International Orders Ships in: 8-12 days
Return Policy: 15-days return on defective items
Payment Option
This Series Of Studies Seeks To Bring About Greater Understanding And Promote Continuing Review Of The Activities And Functions Of The Federal Government. Each Study Focuses On A Specific Program, Evaluating Its Cost And Efficiency, The Extent To Which It Achieves Its Objectives, And The Major Alternative Means Public And Private For Reaching Those Objectives. Yale Brozen, Professor Of Economics At The University Of Chicago And An Adjunct Scholar Of The American Enterprise Institute For Public Policy Research, Is The Director Of The Program.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: How many pages does this book have? A: This book has eighty-two pages. It provides a concise examination of drug regulation and innovation.
- Q: What is the binding type of this book? A: This book is paperback bound. The paperback format makes it lightweight and portable.
- Q: Who is the author of this book? A: The author is Henry G. Grabowski. He is known for his expertise in economics and public policy.
- Q: What subjects does this book cover? A: This book covers subjects related to drug regulation and public policy. It offers empirical evidence and policy options for analysis.
- Q: Is this book suitable for academic use? A: Yes, this book is suitable for academic use. It includes evaluative studies that are beneficial for students and researchers.
- Q: What are the main themes of this book? A: The main themes include drug regulation, innovation, and government efficiency. It presents evaluations of specific programs and their effectiveness.
- Q: How does this book evaluate drug regulation? A: The book evaluates drug regulation by analyzing cost, efficiency, and objectives. It assesses both public and private means to achieve these goals.
- Q: Can I use this book for policy analysis? A: Yes, this book is ideal for policy analysis. It offers insights into federal government activities and alternative means for regulation.
- Q: What is the target audience for this book? A: The target audience includes students, policymakers, and professionals in public health and economics. It appeals to anyone interested in drug policy.
- Q: How should I store this book? A: Store this book in a cool, dry place. Keep it away from direct sunlight to preserve the quality of the paperback binding.
- Q: Is this book safe to read for all ages? A: Yes, this book is safe to read for all ages. It focuses on educational content related to drug policy and regulation.
- Q: How do I care for my paperback book? A: To care for your paperback book, avoid bending the cover and keep it clean. Use a bookmark instead of folding the pages.
- Q: What do I do if my book arrives damaged? A: If your book arrives damaged, contact the seller for a return or exchange. Most sellers have policies in place for damaged goods.
- Q: Is there a warranty for this book? A: No, there is typically no warranty for books. However, you can check the return policy for any issues.
- Q: How do I find more books like this one? A: To find more books like this one, search for titles in the subjects of drug regulation and public policy. Explore academic publishers for similar topics.
- Q: What if I have questions about the content of the book? A: If you have questions about the content, consider reaching out to academic forums or book discussion groups focused on drug policy.